Crossmark

A2A adenosine receptor agonist reduced MMP8 expression in healthy M2-like macrophages but not in macrophages from ankylosing spondylitis patients

Published Online: 2022-10-12

Authors

Sadatpour, Omid

Ebrahimi, Mohammad Taha

Akhtari, Maryam

Ahmadzadeh, Nooshin

Vojdanian, Mahdi

Jamshidi, Ahmadreza

Farhadi, Elham

Mahmoudi, Mahdi
Funding

Funding for this research was provided by:

Tehran University of Medical Sciences‎ (‎99-3-96-51351‎, ‎99-3-96-51351‎)
License Information

Text and Data Mining valid from 2022-10-12

Version of Record valid from 2022-10-12
More Information

Article History

Received: 10 May 2022

Accepted: 23 September 2022

First Online: 12 October 2022

Declarations

:

: This study was performed based on the Declaration of Helsinki guidelines and was approved by the ethics committee at the Tehran University of Medical Sciences (Approval ID: (IR.TUMS.DDRI.REC.1399.047). The written informed consent was signed by all patients before enrolling in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current